GW Pharma's (GWPH) Price Target Raised to $152 at Morgan Stanley
Tweet
Share
E-mailGet Alerts GWPH Hot Sheet
Price: $218.96 --0%
Rating Summary:
13 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 12 | New: 19
Rating Summary:
13 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 12 | New: 19
Join SI Premium – FREE
Morgan Stanley maintained an Overweight rating on GW Pharma (NASDAQ: GWPH) and raised its price target to $152.00 (from $149.00).
For an analyst ratings summary and ratings history on GW Pharma click here. For more ratings news on GW Pharma click here.
Shares of GW Pharma closed at $88.49 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gemini Space Station (GEMI) PT Lowered to $6 at Rosenblatt
- Deutsche Bank Downgrades Netskope (NTSK) to Hold on Valuation
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
Create E-mail Alert Related Categories
Analyst PT Change, Momentum Movers, Short SalesRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
